Sanofi, the pharmaceutical company behind Zantac (ranitidine), has recently announced a significant settlement agreement to resolve approximately 4,000 cancer lawsuits filed in state courts across the United States. Although this settlement marks a step towards resolution, Sanofi still faces tens of thousands of pending claims related to the recalled heartburn drug, the majority of them …
The federal judge overseeing the Zantac multidistrict litigation (MDL) has chosen more than two dozen plaintiffs’ attorneys to serve in leadership positions in the growing litigation over the recalled heartburn drug Zantac and its potential to cause cancer in users. After interviewing 62 attorneys involved in the Zantac MDL, U.S. District Judge Robin L. Rosenberg …
The U.S. Food and Drug Administration (FDA) announced this week that it is asking manufacturers of Zantac and generic ranitidine products to withdraw all prescription and over-the-counter (OTC) versions of the drug from the market immediately. The FDA’s decision is the latest step in an ongoing investigation into the presence of a carcinogenic chemical called …
FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market Read More »
